Press Releases

RDx BioScience In The News

“Smarter” Genetic Risk Testing from RDx BioScience Enhances Safe, Cost Effective Pain Management and High-Quality Addiction Care

February 2, 2019|

KENILWORTH, N.J.--(BUSINESS WIRE)--RDx BioScience (RDx), a single source for care...

RDx BioScience Lauds Passage of H.R.6 Support Act to Fight Opioid Epidemic: Emphasizes Need for Prescriber Education, Drug Testing and Pain Management

November 28, 2018|

KENILWORTH, N.J.--(BUSINESS WIRE)--With the passage of new federal opioid legislation to help prevent...

Flu Season Alert: RDx BioScience Respiratory Pathogen Panel Addresses Antibiotic Resistance to Reduce Unnecessary or Excessive Prescribing

November 15, 2018|

KENILWORTH, N.J.-- (BUSINESS WIRE)--In response to national trends showing that most...

RDx BioScience Appoints Sean Farrell, VP Sales & Strategy:Experienced Strategist, Team Builder for Laboratory and Addiction Treatment to Expand National Footprint

June 5, 2018|

KENILWORTH, N.J.--RDx BioScience (RDx), a leader in full-service diagnostics, delivering...

RDx BioScience Examines the Role of Pharmacogenomic Testing to Lower Medication Costs and Overall Healthcare Expenditures at New York Health Forum

May 23, 2018|

“Collaboration for Success: Multi-Regional Clinical Development,” May 25, 12:30-5...

RDx BioScience Supports Monitoring Gabapentin as ‘Drug of Concern’ Amid Staggering Utilization by Opioid Users and Misuse of Medication as New Way to Get High Lauds adoption of new amendments by NJ Division of Consumer Affairs effective 5.7.2018 to NJ Prescription Monitoring Program rules regarding Rx dispensing of gabapentin

May 8, 2018|

KENILWORTH, N.J.--With increased physician prescribing of the drug gabapentin, RDx BioScience (RDx),...

RDx BioScience Recommends Pharmacogenetic Testing to Improve Clinical Outcomes, Lower Healthcare Costs for Self-Insured Employers

April 25, 2018|

KENILWORTH, N.J.--RDx BioScience (RDx), providers of high quality laboratory and genomic testing, and...

RDx BioScience& MedTek21 Collaboration Delivers Continuous Genomics-Based Medication Monitoring, Improves Outcomes, Cuts Costs for Payers and Plan Sponsors

April 18, 2018|

KENILWORTH, N.J.--RDx BioScience (RDx), providers of high quality laboratory and genomic testing, and...

RDx BioScience Highlights Impact of Drug Abuse in the Workplace, Offers Employment Drug Testing as Powerful Risk Mitigation Tool

January 11, 2018|

KENILWORTH, N.J.--RDx BioScience (RDx), providers of high-quality laboratory and genomic testing...

RDx BioScience Announces Appointments: Preeminent Scientist as Laboratory Director, and Pain and Opioid Prescribing Expert as Director of Provider Relations

November 13, 2017|

KENILWORTH, N.J.--RDx BioScience (RDx), providers of high-quality laboratory and genomic testing...

RDx BioScience Supports President Trump’s Declaration: Opioid Crisis is a Public Health Emergency

October 27, 2017|

Calls for expanded physician prescribing education President Trump’s designation...

RDx BioScience Recommends Genomic Testing to Assess Cancer Risks: Employers & Payers Optimize Clinical Outcomes, Improve Member Satisfaction

October 23, 2017|

KENILWORTH, N.J.--RDx BioScience (RDx), providers of high-quality laboratory and genomic testing, and evidence-based...

RDx BioScience Examines the Future of Alternative Payment Models for Addiction Medicine at N.Y. State Conference of Alcoholism & Substance Abuse Providers

September 18, 2017|

KENILWORTH, N.J.--RDx BioScience(RDx), providers of high-quality laboratory and genomic testing,...

Nation’s Opioid Epidemic, Increase Mandatory Prescriber Education Underwriters of educational grant for a Mandatory Prescriber Education Course in New York state, Tenet seeks to replicate program

August 3, 2017|

Industry Leader Tenet Diagnostics Supports Opioid Commission’s Initiative to Reverse KENILWORTH, N.J.--As an industry leader,...

RDx BioScience Appoints Scott Howell, MD, MPH & TM, CPE, Expert in Clinical Outcomes, Economics and Public Health, as New Chief Medical Officer

July 26, 2017|

KENILWORTH, N.J.--RDx BioScience (RDx), providers of high-quality laboratory and genomic testing and evidence-based research designed...

RDx BioScience Diagnostics Highlights Importance of Pharmacogenomics in Preventing Adverse Drug Reactions, Mitigating Opioid Addiction and Death

July 6, 2017|

KENILWORTH, N.J.--RDx BioScience (RDx) providers of high-quality laboratory and genomic...

RDx BioScience Teams Up with OpiSafe, Offers Physicians Optimal Approach for Prescribing, Managing and Monitoring Opioid Abuse

June 12, 2017|

KENILWORTH, N.J.-- RDx BioScience (RDx), providers of high-quality laboratory and...

RDx BioScience Supports New York Pain Society Annual Meeting, Provides Educational Grant Supporting Mandatory Prescriber Education Course

March 29, 2017|

KENILWORTH, N.J.-- RDx BioScience, (RDx) providers of high-quality laboratory and...